期刊
TRENDS IN CARDIOVASCULAR MEDICINE
卷 10, 期 4, 页码 143-148出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/S1050-1738(00)00044-X
关键词
-
资金
- NHLBI NIH HHS [HL-52233, HL-34836] Funding Source: Medline
- NINDS NIH HHS [NS-10828] Funding Source: Medline
The 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors, or statins, are potent inhibitors of cholesterol synthesis and large clinical trials have demonstrated that these agents reduce cholesterol and the incidence of cardiovascular diseases. Recent evidence, however, suggests that the beneficial effects of statins may extend beyond their effects on serum cholesterol levels. Because statins also inhibit the synthesis of isoprenoid intermediates in the cholesterol biosynthetic pathway, they may have pleiotropic effects on vascular wall cells. In particular, the small GTP-binding protein, Rho, whose membrane localization and activity are affected by post-translational isoprenylation, may play an important role in mediating the direct vascular effects of statins. (Trends Cardiovasc Med 2000;10:143-148). (C) 2001 Elsevier Science Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据